As the exchange seeks more global firms, Insilico Medicine’s IPO in December was a significant moment, while French firm TheraVectys is understood to be considering a listing.
HKEX eyes more global biotechs to build IPO hub
As the exchange seeks more global firms, Insilico Medicine’s IPO in December was a significant moment, while French firm TheraVectys is understood to be considering a listing.